MACKAY JAMIE MYLES 13D and 13G filings for RepliCel Life Sciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-05 2:22 pm Purchase | 2022-12-30 | 13D | RepliCel Life Sciences Inc. REPCF | MACKAY JAMIE MYLES | 8,864,037 16.410% | 2,025,000 (+29.61%) | Filing |
| 2022-09-28 6:08 pm Purchase | 2022-05-04 | 13D | RepliCel Life Sciences Inc. REPCF | MACKAY JAMIE MYLES | 6,839,037 15.220% | 6,839,037 (New Position) | Filing |